The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Abstract
OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of olanzapine for the treatment of acute manic or mixed episodes associated with bipolar disorder in adolescents. METHOD: A 3-week multicenter, parallel, double-blind, randomized placebo-controlled trial was conducted at 24 sites in the United States and two sites in Puerto Rico. The participants were outpatient and inpatient male and female adolescents 13-17 years of age with an acute manic or mixed episode. Subjects received either olanzapine (2.5-20 mg/day [N=107]) or placebo (N=54). The mean change from baseline to endpoint in the Young Mania Rating Scale total score was the primary outcome measure. RESULTS: The mean baseline-to-endpoint change in the Young Mania Rating Scale total score was significantly greater for patients receiving olanzapine relative to patients receiving placebo, and a greater proportion of olanzapine-treated patients met response and remission criteria (44.8% versus 18.5% and 35.2% versus 11.1%, respectively). The mean baseline-to-endpoint weight change was significantly greater for patients receiving olanzapine relative to patients receiving placebo (3.7 kg versus 0.3 kg), and the incidence of treatment-emergent weight gain > or =7% of baseline was higher for olanzapine-treated patients (41.9% versus 1.9%). The mean baseline-to-endpoint changes in prolactin, fasting glucose, fasting total cholesterol, uric acid, and the hepatic enzymes aspartate transaminase and alanine transaminase were significantly greater in patients treated with olanzapine relative to patients receiving placebo. CONCLUSIONS: Olanzapine was effective in the treatment of bipolar mania in adolescent patients. Patients treated with olanzapine, however, had significantly greater weight gain and increases in the levels of hepatic enzymes, prolactin, fasting glucose, fasting total cholesterol, and uric acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
The Overt Aggression Scale for the objective rating of verbal and physical aggression
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.35 · Cited by 1,216
Costello, E. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120067012 · Cited by 1,083
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
LEWINSOHN, P. M., KLEIN, D. N., & SEELEY, J. R. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199504000-00012 · Cited by 772
Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children
WOZNIAK, J., BIEDERMAN, J., KIELY, K., ABLON, J. S., FARAONE, S. V., MUNDY, E., & MENNIN, D. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199507000-00010 · Cited by 717
Self-citationNational Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 591
Olanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Self-citationTohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539
Self-citationStrober, M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290050029007 · Cited by 474
DELBELLO, M. P., SCHWIERS, M. L., ROSENBERG, H. L., & STRAKOWSKI, S. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200210000-00011 · Cited by 443
Self-citationEndocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
CORRELL, C. U., & CARLSON, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 403
KOWATCH, R. A., SUPPES, T., CARMODY, T. J., BUCCI, J. P., HUME, J. H., KROMELIS, M., EMSLIE, G. J., WEINBERG, W. A., & RUSH, A. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200006000-00009 · Cited by 389
Self-citationGeller, B., Craney, J. L., Bolhofner, K., Nickelsburg, M. J., Williams, M., & Zimerman, B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.927 · Cited by 309
Sikich, L., Hamer, R. M., Bashford, R. A., Sheitman, B. B., & Lieberman, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300327 · Cited by 308
Strober, M., Schmidt-Lackner, S., Freeman, R., Bower, S., Lampert, C., & Deantonio, M. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199506000-00012 · Cited by 299
Wagner, K. D., Kowatch, R. A., Emslie, G. J., Findling, R. L., Wilens, T. E., McCague, K., D’Souza, J., Wamil, A., Lehman, R. B., Berv, D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1179 · Cited by 259
Self-citationFrazier, J. A., Biederman, J., Tohen, M., Feldman, P. D., Jacobs, T. G., Toma, V., Rater, M. A., Tarazi, R. A., Kim, G. S., Garfield, S. B., et al. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595568 · Cited by 247
Self-citationRATZONI, G., GOTHELF, D., BRAND-GOTHELF, A., REIDMAN, J., KIKINZON, L., GAL, G., PHILLIP, M., APTER, A., & WEIZMAN, R. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00014 · Cited by 237
Pharmacologic activation of limbic structures and neuroimaging studies of emotions.
Beasley, C. M., Tollefson, G. D., & Tran, P. V. (1997) · PubMed · Cited by 197
A Pilot Controlled Trial of Topiramate for Mania in Children and Adolescents With Bipolar Disorder
Delbello, M. P., Findling, R. L., Kushner, S., Wang, D., Olson, W. H., Capece, J. A., Fazzio, L., & Rosenthal, N. R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000159151.75345.20 · Cited by 180
Self-citationLithium Treatment of Acute Mania in Adolescents: A Large Open Trial
KAFANTARIS, V., COLETTI, D. J., DICKER, R., PADULA, G., & KANE, J. M. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000070247.24125.24 · Cited by 162
A Comparison of Risperidone-Induced Weight Gain Across the Age Span
Safer, D. J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130558.86125.5b · Cited by 152
Elevated Prolactin in Pediatric Patients on Typical and Atypical Antipsychotics
Wudarsky, M., Nicolson, R., Hamburger, S. D., Spechler, L., Gochman, P., Bedwell, J. S., Lenane, M., & RAPOPORT, J. L. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.239 · Cited by 133
Hellings, J. A., Zarcone, J. R., Crandall, K., Wallace, D., & Schroeder, S. R. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595559 · Cited by 132
An Open-Label Trial of Risperidone in Children and Adolescents with Bipolar Disorder
Biederman, J., Mick, E. O., Wozniak, J. R., Aleardi, M., Spencer, T. J., & Faraone, S. V. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.311 · Cited by 124
Self-citationJohnson, J. G., Cohen, P. R., & Brook, J. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1679 · Cited by 121
Clozapine in Adolescent Inpatients with Acute Mania
Masi, G., Mucci, M., & Millepiedi, S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760219135 · Cited by 109
Papatheodorou, G. N., Kutcher, S., Katic, M., & Szalai, J. P. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199504000-00006 · Cited by 100
Lithium treatment of manic episodes with psychotic features in prepubertal children
Varanka, T. M., Weller, R. A., Weller, E. B., & Fristad, M. A. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1557 · Cited by 87
The Effect of Atypical Antipsychotic Agents on Prolactin Levels in Children and Adolescents
Pappagallo, M., & Silva, R. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.359 · Cited by 75
Alfaro, C. L., Wudarsky, M., Nicolson, R., Gochman, P., Sporn, A. L., Lenane, M., & Rapoport, J. L. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760219126 · Cited by 73
Saito, E., Correll, C. U., Gallelli, K. A., McMeniman, M., Parikh, U. H., Malhotra, A. K., & Kafantaris, V. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.350 · Cited by 71
Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness.
Gr, D., & Nieman, G. W. (1983) · PubMed · Cited by 50
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Second generation antipsychotics, such as olanzapine (Tohen et al., 2007), quetiapine (DelBello et al.”
BackgroundYatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Olfson, M., Blanco, C., Wang, S., Laje, G., & Correll, C. U. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3074 · Cited by 449
Metadata
- Authors
- Tohen, M., Kryzhanovskaya, L., Carlson, G., DelBello, M., Wozniak, J., Kowatch, R., Wagner, K., Findling, R., Lin, D., Robertson-Plouch, C., Xu, W., Dittmann, R. W., & Biederman, J.
- Venue
- American Journal of Psychiatry
- Published
- 2007-10
- Volume
- 164
- Issue
- 10
- Pages
- 1547-1556
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2128654468
- Cited by
- 315
- References
- 38
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.